Related references
Note: Only part of the references are listed.Reduced cannabinoid 2 receptor activity increases susceptibility to induced seizures in mice
Lindsey Shapiro et al.
EPILEPSIA (2019)
Cannabinoid CB1 Receptor Antagonist Rimonabant Decreases Levels of Markers of Organ Dysfunction and Alters Vascular Reactivity in Aortic Vessels in Late Sepsis in Rats
M. C. G. Leite-Avalca et al.
INFLAMMATION (2019)
US Renal Data System 2017 Annual Data Report Epidemiology of Kidney Disease in the United States
Rajiv Saran et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2018)
Endocannabinoid-mediated modulation of Gq protein-coupled receptor mediates vascular hyporeactivity to nor-adrenaline during polymicrobial sepsis
Preeti Singh et al.
PHARMACOLOGICAL REPORTS (2018)
The role of CB1 in intestinal permeability and inflammation
Mustafa A. Karwad et al.
FASEB JOURNAL (2017)
Cannabinoid Receptor 2 Modulates Neutrophil Recruitment in a Murine Model of Endotoxemia
Theodore S. Kapellos et al.
MEDIATORS OF INFLAMMATION (2017)
Parameters of the Endocannabinoid System as Novel Biomarkers in Sepsis and Septic Shock
J. Daniel Lafreniere et al.
METABOLITES (2017)
Brain cannabinoid receptor 2: expression, function and modulation
De-Jie Chen et al.
ACTA PHARMACOLOGICA SINICA (2017)
Cannabinoid CB1 and CB2 Receptor Signaling and Bias
Mikkel Soes Ibsen et al.
CANNABIS AND CANNABINOID RESEARCH (2017)
Vasoplegia in sepsis depends on the vascular system, vasopressor, and time-point: a comparative evaluation in vessels from rats subjected to the cecal ligation puncture model
Angelica K. Bernardelli et al.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2016)
The CB2 receptor and its role as a regulator of inflammation
Caroline Turcotte et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2016)
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
Mervyn Singer et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Combined Administration of Human Ghrelin and Human Growth Hormone Attenuates Organ Injury and Improves Survival in Aged Septic Rats
Weng-Lang Yang et al.
MOLECULAR MEDICINE (2016)
Cannabinoid Type 2 Receptors Mediate a Cell Type-Specific Plasticity in the Hippocampus
A. Vanessa Stempel et al.
NEURON (2016)
INVOLVEMENT OF CENTRAL ENDOTHELIN ETA AND CANNABINOID CB1 RECEPTORS AND ARGININE VASOPRESSIN RELEASE IN SEPSIS INDUCED BY CECAL LIGATION AND PUNCTURE IN RATS
Mariane C. G. Leite-Avalca et al.
SHOCK (2016)
Cannabinoid 2 receptor activation reduces leukocyte adhesion and improves capillary perfusion in the iridial microvasculature during systemic inflammation
J. T. Toguri et al.
CLINICAL HEMORHEOLOGY AND MICROCIRCULATION (2015)
Protective effect of astaxanthin against multiple organ injury in a rat model of sepsis
Liping Zhou et al.
JOURNAL OF SURGICAL RESEARCH (2015)
Role of the Endocannabinoid System in the Neuroendocrine Responses to Inflammation
Andrea Laurentiis et al.
CURRENT PHARMACEUTICAL DESIGN (2014)
Experimental Cannabinoid 2 Receptor-Mediated Immune Modulation in Sepsis
J. Sardinha et al.
MEDIATORS OF INFLAMMATION (2014)
Modulating the endocannabinoid system in human health and disease successes and failures
Pal Pacher et al.
FEBS JOURNAL (2013)
Cannabinoid Receptor 2 Protects against Acute Experimental Sepsis in Mice
Huan Gui et al.
MEDIATORS OF INFLAMMATION (2013)
Circulatory Shock
Jean-Louis Vincent et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Matrix Metalloprotease 9 Mediates Neutrophil Migration into the Airways in Response to Influenza Virus-Induced Toll-Like Receptor Signaling
Linda M. Bradley et al.
PLOS PATHOGENS (2012)
The Cannabinoid 2 Receptor as a Potential Therapeutic Target for Sepsis
Kevin Richard Kasten et al.
Endocrine Metabolic & Immune Disorders-Drug Targets (2012)
Anti-Obesity Drugs: A Review about Their Effects and Safety
Jun Goo Kang et al.
DIABETES & METABOLISM JOURNAL (2012)
Cannabinoid receptor 2 activation reduces intestinal leukocyte recruitment and systemic inflammatory mediator release in acute experimental sepsis
Christian Lehmann et al.
CRITICAL CARE (2012)
Early potassium channel blockade improves sepsis-induced organ damage and cardiovascular dysfunction
R. Sordi et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Increasing endogenous 2-arachidonoylglycerol levels counteracts colitis and related systemic inflammation
Mireille Alhouayek et al.
FASEB JOURNAL (2011)
Fatty acid amide hydrolase is a key regulator of endocannabinoid-induced myocardial tissue injury
Partha Mukhopadhyay et al.
FREE RADICAL BIOLOGY AND MEDICINE (2011)
The hypothermic response to bacterial lipopolysaccharide critically depends on brain CB1, but not CB2 or TRPV1, receptors
Alexandre A. Steiner et al.
JOURNAL OF PHYSIOLOGY-LONDON (2011)
Characteristics of plasma NOx levels in severe sepsis: high interindividual variability and correlation with illness severity, but lack of correlation with cortisol levels
J. T. Ho et al.
CLINICAL ENDOCRINOLOGY (2010)
The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis
Mitchell M. Levy et al.
INTENSIVE CARE MEDICINE (2010)
Opposing Actions of Endothelin-1 on Glutamatergic Transmission onto Vasopressin and Oxytocin Neurons in the Supraoptic Nucleus
Aleksander R. Zampronio et al.
JOURNAL OF NEUROSCIENCE (2010)
Endocannabinoid System Participates in Neuroendocrine Control of Homeostasis
Andrea De Laurentiis et al.
NEUROIMMUNOMODULATION (2010)
International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2
R. G. Pertwee et al.
PHARMACOLOGICAL REVIEWS (2010)
Endogenous cannabinoids induce fever through the activation of CB1 receptors
D. Fraga et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Antagonism of the cannabinoid CB-1 receptor protects rat liver against ischaemia-reperfusion injury complicated by endotoxaemia
P. Caraceni et al.
GUT (2009)
Early Maternal Deprivation Induces Gender-Dependent Changes on the Expression of Hippocampal CB1 and CB2 Cannabinoid Receptors of Neonatal Rats
Juan Suarez et al.
HIPPOCAMPUS (2009)
The Cannabinoid Receptor 2 Is Critical for the Host Response to Sepsis
Johannes Tschoep et al.
JOURNAL OF IMMUNOLOGY (2009)
CB2 Cannabinoid Receptors Contribute to Bacterial Invasion and Mortality in Polymicrobial Sepsis
Balazs Csoka et al.
PLOS ONE (2009)
CENTRAL CANNABINOID 1 RECEPTOR ANTAGONIST ADMINISTRATION PREVENTS ENDOTOXIC HYPOTENSION AFFECTING NOREPINEPHRINE RELEASE IN THE PREOPTIC ANTERIOR HYPOTHALAMIC AREA
Alex Villanueva et al.
SHOCK (2009)
Should peripheral CB1 cannabinoid receptors be selectively targeted for therapeutic gain?
George Kunos et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2009)
Endocannabinoids and liver disease. I. Endocannabinoids and their receptors in the liver
A. Mallat et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2008)
Alterations in forearm vascular reactivity in patients with septic shock
P. Kienbaum et al.
ANAESTHESIA (2008)
CB2 receptors in the brain: role in central immune function
G. A. Cabral et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Modulation of the endocannabinoid system in cardiovascular disease - Therapeutic potential and limitations
Pal Pacher et al.
HYPERTENSION (2008)
Targeting endocannabinoid degradation protects against experimental colitis in mice:: involvement of CB1 and CB2 receptors
Martin A. Storr et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2008)
Sepsis
James M. O'Brien et al.
AMERICAN JOURNAL OF MEDICINE (2007)
Differential effects of vasopressin and norepinephrine on vascular reactivity in a long-term rodent model of sepsis
Lucinda K. Barrett et al.
CRITICAL CARE MEDICINE (2007)
A novel role of cannabinoids: Implication in the fever induced by bacterial lipopolysaccharide
Khalid Benamar et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Matrix metalloproteinase-9 deficiency impairs host defense against abdominal sepsis
Rosemarijn Renckens et al.
JOURNAL OF IMMUNOLOGY (2006)
Cannabinoid CB2 receptors: Immunohistochemical localization in rat brain
JP Gong et al.
BRAIN RESEARCH (2006)
The emerging role of the endocannabinoid system in endocrine regulation and energy balance
U Pagotto et al.
ENDOCRINE REVIEWS (2006)
The endocannabinoid system as an emerging target of pharmacotherapy
Pal Pacher et al.
PHARMACOLOGICAL REVIEWS (2006)
Activation of the peripheral endocannabinoid system in human obesity
S Engeli et al.
DIABETES (2005)
Blood pressure regulation by endocannabinoids and their receptors
P Pacher et al.
NEUROPHARMACOLOGY (2005)
Fever and hypothermia in systemic inflammation: Recent discoveries and revisions
AA Romanovsky et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2005)
The endogenous cannabinoid system protects against colonic inflammation
F Massa et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Of mice and not men: Differences between mouse and human immunology
J Mestas et al.
JOURNAL OF IMMUNOLOGY (2004)
The endocannabinoid system: a general view and latest additions
L De Petrocellis et al.
BRITISH JOURNAL OF PHARMACOLOGY (2004)
Cannabinoids suppress synaptic input to neurones of the rat dorsal motor nucleus of the vagus nerve
AV Derbenev et al.
JOURNAL OF PHYSIOLOGY-LONDON (2004)
Regional and temporal changes in cardiovascular responses to norepinephrine and vasopressin during continuous infusion of lipopolysaccharide in conscious rats
T Bennett et al.
BRITISH JOURNAL OF ANAESTHESIA (2004)
Presynaptic cannabinoid CB1 receptors are involved in the inhibition of the neurogenic vasopressor response during septic shock in pithed rats
G Godlewski et al.
BRITISH JOURNAL OF PHARMACOLOGY (2004)
Endocannabinoids acting at cannabinoid-1 receptors regulate cardiovascular function in hypertension
S Bátkai et al.
CIRCULATION (2004)
Role of cannabinoid CB1 receptors and tumor necrosis factor-α in the gut and systemic anti-inflammatory activity of SR 141716 (Rimonabant) in rodents
T Croci et al.
BRITISH JOURNAL OF PHARMACOLOGY (2003)
Circulating vasopressin levels in septic shock
T Sharshar et al.
CRITICAL CARE MEDICINE (2003)
Reduction of human monocytic cell neurotoxicity and cytokine secretion by ligands of the cannabinoid-type CB2 receptor
A Klegeris et al.
BRITISH JOURNAL OF PHARMACOLOGY (2003)
Cannabinoids acting on CB1 receptors decrease contractile performance in human atrial muscle
A Bonz et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2003)
Initial sequencing and comparative analysis of the mouse genome
RH Waterston et al.
NATURE (2002)
International Union of Pharmacology. XXVII. Classification of cannabinoid receptors
AC Howlett et al.
PHARMACOLOGICAL REVIEWS (2002)
Molecular biology of cannabinoid receptors
B Lutz
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2002)
Endogenous cannabinoids mediate hypotension after experimental myocardial infarction
JA Wagner et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2001)
The anti-inflammatory activities of cannabinoid receptor ligands in mouse peritonitis models
SR Smith et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2001)
Mechanisms of disease: The pathogenesis of vasodilatory shock
DW Landry et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Simultaneous measurement of anandamide and 2-arachidonoylglycerol by polymyxin B-selective adsorption and subsequent high-performance liquid chromatography analysis: Increase in endogenous cannabinoids in the sera of patients with endotoxic shock
Y Wang et al.
ANALYTICAL BIOCHEMISTRY (2001)
2-arachidonylglycerol, an endogenous cannabinoid, inhibits tumor necrosis factor-α production in murine macrophages, and in mice
R Gallily et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2000)
Share Paper
